Dalarna University's logo and link to the university's website

du.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial
Karolinska Institutet, Stockholm; Karolinska University Hospital, Stockholm.
Dalarna University, School of Health and Welfare, Sexual Reproductive Perinatal Health. Karolinska Institutet, Stockholm.ORCID iD: 0000-0003-2813-7642
Karolinska Institutet, Stockholm; Karolinska University Hospital, Stockholm.
Karolinska Institutet, Stockholm; Danderyd Hospital, Stockholm.
Show others and affiliations
2024 (English)In: Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, E-ISSN 1600-0412, Vol. 103, no 5, p. 873-883Article in journal (Refereed) Published
Sustainable development
SDG 3: Good health and well-being, SDG 5: Gender equality
Abstract [en]

INTRODUCTION: Highly effective long-acting reversible contraceptive (LARC) methods reduce unintended pregnancy rates; however, these methods are underutilized. The LOWE trial intervention provided structured contraceptive counseling resulting in increased uptake of LARC. This longitudinal follow up of the LOWE study assessed the long-term impact of the intervention by investigating the contraceptive use at 12 months with a focus on continued use of LARC.

MATERIAL AND METHODS: In the cluster randomized LOWE trial, abortion, youth, and maternal health clinics were randomized to provide either structured contraceptive counseling (intervention) or standard contraceptive counseling (control). The intervention consisted of an educational video on contraceptive methods, key questions asked by the health care provider, a tiered effectiveness chart and a box of contraceptive models. Women ≥ age 18, who were sexually active or planned to be in the upcoming 6 months, could participate in the study. We assessed self-reported contraceptive use at three, six and 12 months. Contraceptive choice and switches were analyzed with descriptive statistics. Contraceptive use at 12 months and continued use of LARC were analyzed using mixed logistic regressions, with clinic included as a random effect. Analysis with imputed values were performed for missing data to test the robustness of results.

RESULTS: Overall, at 12 months, women in the intervention group were more likely to be using a LARC method (aOR 1.90, 95% CI: 1.31-2.76) and less likely to be using a short-acting reversible contraceptive (SARC) method (aOR 0.66, 95% CI: 0.46-0.93) compared to the control group. Women counseled at abortion (aOR 2.97, 95% CI: 1.36-6.75) and youth clinics (aOR 1.81, 95% CI: 1.08-3.03) were more likely to be using a LARC method, while no significant difference was seen in maternal health clinics (aOR 1.84, 95% CI: 0.96-3.66). Among women initiating LARC, continuation rates at 12 months did not differ between study groups (63.9% vs. 63.7%). The most common reasons for contraceptive discontinuation were wish for pregnancy, followed by irregular bleeding, and mood changes.

CONCLUSIONS: The LOWE trial intervention resulted in increased LARC use also at 12 months. Strategies on how to sustain LARC use needs to be further investigated.

Place, publisher, year, edition, pages
2024. Vol. 103, no 5, p. 873-883
Keywords [en]
LARC, choice, continuation, contraception, contraceptive-counseling, long-acting reversible contraception, unintended pregnancy
National Category
Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:du-48069DOI: 10.1111/aogs.14792ISI: 001161861900001PubMedID: 38351571Scopus ID: 2-s2.0-85185438966OAI: oai:DiVA.org:du-48069DiVA, id: diva2:1839517
Available from: 2024-02-21 Created: 2024-02-21 Last updated: 2025-02-20Bibliographically approved

Open Access in DiVA

fulltext(2163 kB)106 downloads
File information
File name FULLTEXT01.pdfFile size 2163 kBChecksum SHA-512
5e61422607078778b1fccdf040eaab7fe2a1df661eca6d3b501b8d64c02c408e1419910ede27ca6b7de28023fd8af2192d70301d9f53b0e4f7a8be9d04a2ec4e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Envall, Niklas

Search in DiVA

By author/editor
Envall, Niklas
By organisation
Sexual Reproductive Perinatal Health
In the same journal
Acta Obstetricia et Gynecologica Scandinavica
Public Health, Global Health and Social Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 106 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 209 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf